 | Up a level |
Mach, François; Baigent, Colin; Catapano, Alberico L; Koskinas, Konstantinos C.; Casula, Manuela; Badimon, Lina; Chapman, M John; De Backer, Guy G; Delgado, Victoria; Ference, Brian A; Graham, Ian M; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R; Riccardi, Gabriele; Richter, Dimitrios J; Sabatine, Marc S; Taskinen, Marja-Riitta; Tokgozoglu, Lale; ... (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European heart journal, 41(1), pp. 111-188. Oxford University Press 10.1093/eurheartj/ehz455
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). New prospects for PCSK9 inhibition? European Heart Journal, 39(27), pp. 2600-2601. Oxford University Press 10.1093/eurheartj/ehy147
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. European Heart Journal, 39(14), pp. 1131-1143. Oxford University Press 10.1093/eurheartj/ehx549
